H
Hristos Z. Kaimakliotis
Researcher at Indiana University
Publications - 102
Citations - 1224
Hristos Z. Kaimakliotis is an academic researcher from Indiana University. The author has contributed to research in topics: Bladder cancer & Cystectomy. The author has an hindex of 16, co-authored 84 publications receiving 825 citations. Previous affiliations of Hristos Z. Kaimakliotis include Wayne State University & Indiana University Health.
Papers
More filters
Journal ArticleDOI
Staging of Bladder Cancer
Martin J. Magers,Antonio Lopez-Beltran,Rodolfo Montironi,Sean R. Williamson,Sean R. Williamson,Hristos Z. Kaimakliotis,Liang Cheng,Liang Cheng +7 more
TL;DR: Several critical changes and clarifications are made by the AJCC 8th edition relative to the 7th edition, and modifications are discussed, as well as points, which require further study and optimisation.
Journal ArticleDOI
Contemporary bladder cancer: Variant histology may be a significant driver of disease
M. Francesca Monn,Hristos Z. Kaimakliotis,Jose A. Pedrosa,K. Clint Cary,Richard Bihrle,Liang Cheng,Michael O. Koch +6 more
TL;DR: MPV and PCV were independently associated with twice the risk of all-cause mortality compared with nonvariant, when adjusting for demographics, American Society of Anesthesiologists class, transurethral resection of bladder tumor stage, cystectomy stage, positive lymph nodes, and reception of chemotherapy.
Journal ArticleDOI
Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial
Nir Kleinmann,Surena F. Matin,Phillip M. Pierorazio,John L. Gore,Ahmad Shabsigh,Brian Hu,Karim Chamie,Guilherme Godoy,Scott G. Hubosky,Marcelino E. Rivera,Michael A. O’Donnell,Marcus L. Quek,Jay D. Raman,John J. Knoedler,Douglas S. Scherr,Joshua Stern,Christopher J. Weight,Alon Z. Weizer,Michael Woods,Hristos Z. Kaimakliotis,Angela B. Smith,Jennifer M Linehan,Jonathan A. Coleman,Mitchell R. Humphreys,Raymond Pak,David A. Lifshitz,Michael Verni,Mehrad Adibi,Mahul B. Amin,Elyse Seltzer,Ifat Klein,Marina Konorty,Dalit Strauss-Ayali,Gil Hakim,Mark Schoenberg,Seth P. Lerner +35 more
TL;DR: Primary chemoablation of low-grade upper tract urothelial cancer with intracavitary UGN-101 results in clinically significant disease eradication and might offer a kidney-sparing treatment alternative for these patients.
Journal ArticleDOI
Plasmacytoid bladder cancer: variant histology with aggressive behavior and a new mode of invasion along fascial planes.
Hristos Z. Kaimakliotis,M. Francesca Monn,Liang Cheng,Timothy A. Masterson,K. Clint Cary,Jose A. Pedrosa,Richard S. Foster,Michael O. Koch,Richard Bihrle +8 more
TL;DR: PCV exhibits a unique pattern of spread along the ureter that proposes a new mode of invasion along the fascial sheath, and in conjunction with the increased incidence of +UM, may lead to a paradigm shift, with surgeons and pathologists being more vigilant with surgical margins.
Journal ArticleDOI
Plasmacytoid variant urothelial bladder cancer: Is it time to update the treatment paradigm?
Hristos Z. Kaimakliotis,M. Francesca Monn,K. Clint Cary,Jose A. Pedrosa,Kevin R. Rice,Timothy A. Masterson,Thomas A. Gardner,Noah M. Hahn,Richard S. Foster,Richard Bihrle,Liang Cheng,Michael O. Koch +11 more
TL;DR: In this paper, a retrospective analysis of the Indiana University Bladder Cancer Database between January 2008 and June 2013 was performed comparing 30 patients with PCV UC at cystectomy to 278 patients with nonvariant (NV) urothelial cancer (UC) who underwent surgery for muscle-invasive disease.